363 related articles for article (PubMed ID: 35805104)
1. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.
Ahmed MB; Alghamdi AAA; Islam SU; Lee JS; Lee YS
Cells; 2022 Jun; 11(13):. PubMed ID: 35805104
[TBL] [Abstract][Full Text] [Related]
2. Epac and PKA: a tale of two intracellular cAMP receptors.
Cheng X; Ji Z; Tsalkova T; Mei F
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):651-62. PubMed ID: 18604457
[TBL] [Abstract][Full Text] [Related]
3. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.
Zhang H; Liu Y; Liu J; Chen J; Wang J; Hua H; Jiang Y
J Hematol Oncol; 2024 Jan; 17(1):5. PubMed ID: 38233872
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments.
DiPilato LM; Cheng X; Zhang J
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16513-8. PubMed ID: 15545605
[TBL] [Abstract][Full Text] [Related]
5. cAMP signaling in subcellular compartments.
Lefkimmiatis K; Zaccolo M
Pharmacol Ther; 2014 Sep; 143(3):295-304. PubMed ID: 24704321
[TBL] [Abstract][Full Text] [Related]
6. PKIB, a Novel Target for Cancer Therapy.
Musket A; Moorman JP; Zhang J; Jiang Y
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731883
[TBL] [Abstract][Full Text] [Related]
7. The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.
Bolger GB
Front Endocrinol (Lausanne); 2022; 13():1024423. PubMed ID: 36313756
[TBL] [Abstract][Full Text] [Related]
8. Epac as a tractable therapeutic target.
Slika H; Mansour H; Nasser SA; Shaito A; Kobeissy F; Orekhov AN; Pintus G; Eid AH
Eur J Pharmacol; 2023 Apr; 945():175645. PubMed ID: 36894048
[TBL] [Abstract][Full Text] [Related]
9. cAMP-Dependent Signaling and Ovarian Cancer.
Kilanowska A; Ziółkowska A; Stasiak P; Gibas-Dorna M
Cells; 2022 Nov; 11(23):. PubMed ID: 36497095
[TBL] [Abstract][Full Text] [Related]
10. The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.
Fujishita T; Kojima Y; Kajino-Sakamoto R; Mishiro-Sato E; Shimizu Y; Hosoda W; Yamaguchi R; Taketo MM; Aoki M
Cancer Res; 2022 Nov; 82(22):4179-4190. PubMed ID: 36066360
[TBL] [Abstract][Full Text] [Related]
11. CREB-associated glycosylation and function in human disease.
Zhang N; Shi L; Wang Y
Adv Clin Exp Med; 2022 Nov; 31(11):1289-1297. PubMed ID: 35951625
[TBL] [Abstract][Full Text] [Related]
12. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.
de Rooij J; Zwartkruis FJ; Verheijen MH; Cool RH; Nijman SM; Wittinghofer A; Bos JL
Nature; 1998 Dec; 396(6710):474-7. PubMed ID: 9853756
[TBL] [Abstract][Full Text] [Related]
13. A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation.
Drozdz MM; Doane AS; Alkallas R; Desman G; Bareja R; Reilly M; Bang J; Yusupova M; You J; Eraslan Z; Wang JZ; Verma A; Aguirre K; Kane E; Watson IR; Elemento O; Piskounova E; Merghoub T; Zippin JH
Cell Rep; 2022 Sep; 40(13):111412. PubMed ID: 36170819
[TBL] [Abstract][Full Text] [Related]
14. Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.
Pan Y; Liu J; Ren J; Luo Y; Sun X
Front Pharmacol; 2022; 13():929152. PubMed ID: 35910387
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary screening of precision oncology biomarkers and its applications in prognostic model construction.
Zhang ZW; Zhang KX; Liao X; Quan Y; Zhang HY
iScience; 2024 Jun; 27(6):109859. PubMed ID: 38799582
[TBL] [Abstract][Full Text] [Related]
16. Identifying Key Regulatory Genes in Drug Resistance Acquisition: Modeling Pseudotime Trajectories of Breast Cancer Single-Cell Transcriptome.
Iida K; Okada M
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791962
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-regulatory element-binding protein: a novel UV-targeted transcription factor in skin cancer.
Nayar JC; Abboud M; Dixon KM
Photochem Photobiol Sci; 2024 May; ():. PubMed ID: 38743195
[TBL] [Abstract][Full Text] [Related]
18. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression.
Yan C; Yang Z; Chen P; Yeh Y; Sun C; Xie T; Huang W; Zhang X
J Exp Clin Cancer Res; 2024 Apr; 43(1):105. PubMed ID: 38576043
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract][Full Text] [Related]
20. [Demethylzeylasteral inhibits proliferation, migration and invasion and promotes apoptosis of non-small cell lung cancer cells by inhibiting the AKT/CREB signaling pathway].
Han Q; Ye M; Jin Q
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):280-288. PubMed ID: 38501413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
